The International Federation of Pharmaceutical Manufacturers and Associations has announced the results of an update of its 2005 Health Partnerships Survey of the R&D-based pharmaceutical industry's contribution to help attain the health-related United Nations' Millennium Development Goals.
In the period 2000 to 2006, the industry has collectively made available more than 1.3 billion health interventions to help improve the lives of people living in developing countries. These can be broken down into the following principal categories: medicines, vaccines and diagnostics - both donated and no profit; other health care interventions, education for patients and people at risk; and training for health workers.
The assistance provided by the pharmaceutical industry to the developing world in this period, including donations of medicines, vaccines, diagnostics, equipment, other material and labor has been valued at some $6.70 billion, with the donated medicines included at their wholesale prices.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze